NGS for precision medicine in non-small cell lung cancer: Challenges and opportunities V. Mileyko1, M. Ivanov1, E. Novikova2, E. Telysheva2, P. Chernenko3, V. Breder3, K. Laktionov3 and A. Baranova4 1Laboratory of Molecular Medicine, Institute of Chemical Biology and Fundamental Medicine, Novosibirsk, Russian Federation 2Laboratory of Molecular Biology and Cytogenetics, Russian Scientific Center of Radiology and Nuclear Medicine, Moscow, Russian Federation 3Department of Clinical Biotechnologies, N. N.